Clinical Trial Update: Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors. [Phase 3]

View source ↗

Summary

This clinical trial update indicates a Phase 3 study of systemic targeted adaptive radiotherapy for neuroendocrine tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumor

Snippet

Sponsor: Lund University Hospital | Conditions: Neuroendocrine Tumors | Phase 3 | Status: RECRUITING